Canada markets closed

Akebia Therapeutics, Inc. (AX9.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.9960-0.0430 (-4.14%)
At close: 08:01AM CEST
Currency in EUR
Earnings EstimateCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
No. of Analysts6656
Avg. Estimate-0.33-0.29-1.59-0.78
Low Estimate-0.42-0.44-1.83-1.12
High Estimate-0.27-0.16-1.47-0.37
Year Ago EPS-0.42-0.6-2.77-1.59
Revenue EstimateCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
No. of Analysts5566
Avg. Estimate47.31M54.39M208.77M272.86M
Low Estimate35.1M45M193M224.32M
High Estimate59.7M62.8M229.21M377.07M
Year Ago Sales59.99M56.7M295.31M208.77M
Sales Growth (year/est)-21.10%-4.10%-29.30%30.70%
Earnings History2020-09-302020-12-312021-03-312021-06-30
EPS Est.-0.17-0.4-0.29-0.32
EPS Actual-0.42-0.6-0.45-0.51
Difference-0.25-0.2-0.16-0.19
Surprise %-147.10%-50.00%-55.20%-59.40%
EPS TrendCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
Current Estimate-0.33-0.29-1.59-0.78
7 Days Ago-0.33-0.29-1.59-0.78
30 Days Ago-0.33-0.29-1.59-0.78
60 Days Ago-0.3-0.29-1.35-0.78
90 Days Ago-0.3-0.29-1.35-0.78
EPS RevisionsCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesAX9.FIndustrySector(s)S&P 500
Current Qtr.21.40%N/AN/AN/A
Next Qtr.51.70%N/AN/AN/A
Current Year42.60%N/AN/AN/A
Next Year50.90%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A